107 related articles for article (PubMed ID: 10220483)
1. Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes.
Baune B; Furlan V; Taburet AM; Farinotti R
Drug Metab Dispos; 1999 May; 27(5):565-8. PubMed ID: 10220483
[TBL] [Abstract][Full Text] [Related]
2. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors.
Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K
Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
Boxenbaum H
J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769
[TBL] [Abstract][Full Text] [Related]
5. Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs.
Bangchang KN; Karbwang J; Back DJ
Biochem Pharmacol; 1992 Aug; 44(3):587-90. PubMed ID: 1510705
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tolbutamide metabolism by antimalarial drugs.
Karbwang J; Back DJ; Bunnag D; Breckenridge AM
Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):235-41. PubMed ID: 3227403
[TBL] [Abstract][Full Text] [Related]
8. Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes.
Zhao XJ; Ishizaki T
Br J Clin Pharmacol; 1997 Nov; 44(5):505-11. PubMed ID: 9384469
[TBL] [Abstract][Full Text] [Related]
9. Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs.
Bangchang KN; Karbwang J; Back DJ
Biochem Pharmacol; 1992 May; 43(9):1957-61. PubMed ID: 1596283
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
11. The stereoselective metabolism of halofantrine to desbutylhalofantrine in the rat: evidence of tissue-specific enantioselectivity in microsomal metabolism.
Gharavi N; Sattari S; Shayeganpour A; El-Kadi AO; Brocks DR
Chirality; 2007 Jan; 19(1):22-33. PubMed ID: 17089336
[TBL] [Abstract][Full Text] [Related]
12. Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism.
Tang W; Stearns RA; Kwei GY; Iliff SA; Miller RR; Egan MA; Yu NX; Dean DC; Kumar S; Shou M; Lin JH; Baillie TA
J Pharmacol Exp Ther; 1999 Dec; 291(3):1068-74. PubMed ID: 10565826
[TBL] [Abstract][Full Text] [Related]
13. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
[TBL] [Abstract][Full Text] [Related]
14. An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.
Mei L; Zhang L; Dai R
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):753-62. PubMed ID: 18956271
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes.
Cherstniakova SA; Bi D; Fuller DR; Mojsiak JZ; Collins JM; Cantilena LR
Drug Metab Dispos; 2001 Sep; 29(9):1216-20. PubMed ID: 11502731
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
Daniel WA; Syrek M; Haduch A
Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
[TBL] [Abstract][Full Text] [Related]
17. FK 506 (Tacrolimus) metabolism by rat liver microsomes and its inhibition by other drugs.
Prasad TN; Stiff DD; Subbotina N; Zemaitis MA; Burckart GJ; Starzl TE; Venkataramanan R
Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):35-46. PubMed ID: 7518966
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
19. Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity.
Wang YJ; Yu CF; Chen LC; Chen CH; Lin JK; Liang YC; Lin CH; Lin SY; Chen CF; Ho YS
J Cell Biochem; 2002; 87(2):147-59. PubMed ID: 12244568
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes.
Liu XQ; Zhao Y; Li D; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2003 Mar; 24(3):263-8. PubMed ID: 12617777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
